Compare ImmunityBio Inc. Common Stock (IBRX) vs Vanguard Value Index Fund ETF (VTV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Vanguard Value Index Fund ETF — how do they compare? ImmunityBio Inc. Common Stock trades at $10.46 (market cap $10.51B), while Vanguard Value Index Fund ETF trades at $220.15 (market cap $262.40B). The key difference: Vanguard Value Index Fund ETF is far larger — about 25× ImmunityBio Inc. Common Stock's market cap, and ImmunityBio Inc. Common Stock is more actively traded (10,445,785 versus 3,293,281). Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Vanguard Value Index Fund ETF for 142 Days on average.
| IBRX | VTV | |
|---|---|---|
Market Cap | $10.51B | $262.40B |
Volume | 10,445,785 | 3,293,281 |
Sector | Health | — |
52-Week High | $11.55 | $227.51 |
52-Week Low | $1.98 | $182.86 |
Typical Hold Time | 0 Days | 142 Days |
Enterprise Value | $10.97B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VTV trades at $219.97, up 0.81% with a bearish technical signal from moving averages. The ETF shows neutral oscillator readings but faces selling pressure from institutional indicators. Recent news highlights value stock outperformance in 2026, with VTV beating growth counterparts by significant margins. The fund offers a 2.3% dividend yield and low 0.03% expense ratio, attracting income-focused investors amid market rotation from growth to value strategies.
VTV presents a compelling value proposition with strong 2026 performance and institutional accumulation. However, technical weakness and long-term underperformance versus broad market indices pose risks. The ETF's low-cost structure and dividend yield support defensive positioning, but investors should weigh recent momentum against historical tracking error concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Vanguard Value Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the CRSP US Large Cap Value Index, a broadly diversified index predominantly made up of value stocks of large US companies. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VTV →
